Angelica L Quartino (Angelica Quartino)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Low Density Lipoprotein

Coronary Artery

Early Breast Cancer

Top Venues

Journal of the American Heart Association

CPT: pharmacometrics & systems pharmacology

Cancer chemotherapy and pharmacology

Alzheimer's research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Samira Jamalian, Michael Dolton, Pascal Chanu, Vidya Ramakrishnan, Yesenia Franco, Kristin Wildsmith, Paul Manser, Edmond Teng, Jin Yan Jin, Angelica L Quartino, Joy C Hsu, null null
Modeling Alzheimer's Disease Progression Utilizing Clinical Trial and ADNI Data to Predict Longitudinal Trajectory of CDR-SB. CPT: pharmacometrics & systems pharmacology (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Samira Jamalian, Michael Dolton, Pascal Chanu, Vidya Ramakrishnan, Yesenia Franco, Kristin Wildsmith, Paul Manser, Edmond Teng, Jin Yan Jin, Angelica L Quartino, Joy C Hsu, null null
Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB. CPT: pharmacometrics & systems pharmacology (2023)
Phyllis Chan, Han Ting Ding, Bianca M Liederer, Jialin Mao, Paula Belloni, Liuxi Chen, Simon S Gao, Victory Joseph, Xiaoying Yang, Joseph S Lin, Mayur S Mitra, Wendy S Putnam, Angelica L Quartino, Rebecca N Bauer, Lin Pan
Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor. Clinical and translational science 14 (5) (2021)
Bei Wang, Rong Deng, Stefanie Hennig, Tanja Badovinac Crnjevic, Monika Kaewphluk, Matts Kågedal, Angelica L Quartino, Sandhya Girish, Chunze Li, Whitney P Kirschbrown
Correction to: Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer chemotherapy and pharmacology (2021)
Bei Wang, Rong Deng, Stefanie Hennig, Tanja Badovinac Crnjevic, Monika Kaewphluk, Matts Kågedal, Angelica L Quartino, Sandhya Girish, Chunze Li, Whitney P Kirschbrown
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer chemotherapy and pharmacology 88 (3) (2021)
Kenta Yoshida, Anita Moein, Tobias Bittner, Susanne Ostrowitzki, Helen Lin, Lee Honigberg, Jin Y Jin, Angelica L Quartino
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease. Alzheimer's research & therapy 12 (1) (2020)